UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology

The international journal of tuberculosis and lung disease, 2016-07, Vol.20 (7), p.934-940

2016

Volltextzugriff (PDF)

Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia

The international journal of tuberculosis and lung disease, 2013-06, Vol.17 (6), p.836-841

2013

Volltextzugriff (PDF)

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

British journal of cancer, 2014-02, Vol.110 (4), p.984-990

2014

Volltextzugriff (PDF)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

British journal of cancer, 2015-03, Vol.112 (5), p.783-792

2015

Volltextzugriff (PDF)

Coaching to develop teacher professional noticing: planning with students and mathematics in mind

International journal of mentoring and coaching in education, 2021-08, Vol.10 (3), p.339-354

Jakopovic, Paula M

2021

Volltextzugriff (PDF)

Reconceptualizing risk: toward a theory of small risks in informal family play settings

Frontiers in education (Lausanne), 2024-08, Vol.9

2024

Volltextzugriff (PDF)

Persistent endothelial dysfunction turns the frequent exacerbator COPD from respiratory disorder into a progressive pulmonary and systemic vascular disease

Medical hypotheses, 2015-02, Vol.84 (2), p.155-158

2015

Volltextzugriff (PDF)

SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS

Lymphology, 2015-06, Vol.48 (2), p.97-102

2015

Volltextzugriff (PDF)

Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature

Transplant infectious disease, 2016-02, Vol.18 (1), p.112-119

2016

Volltextzugriff (PDF)

1394P Real-world experience in treatment of patients with non-small cell lung cancer with BRAF and cMET Exon 14 skipping mutations

Annals of oncology, 2023-10, Vol.34, p.S798-S799

2023

Volltextzugriff (PDF)

107P IMPACT OF PREINTERVENTIONAL PLASMA FIBRINOGEN AS A PROGNOSTIC MARKER IN MALIGNANT PLEURAL MESOTHELIOMA

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S46-S46

2013

Volltextzugriff (PDF)

EP07.01-012 Ipilimumab and Nivolumab in Pretreated Patients with Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S318

2022

Volltextzugriff (PDF)

EP11.01-03 Neutrophil to Lymphocite Ratio in Patients Treated with Immunotherapy after Progression on Chemotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S611

2023

Volltextzugriff (PDF)

P2.04-01 Lung Cancer Patient Experience Survey from Twelfth Central and Eastern Europe Countries

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S132

2022

Volltextzugriff (PDF)

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

The European respiratory journal, 2018-08, Vol.52 (2), p.1701190

2018

Volltextzugriff (PDF)

EP07.02-001 Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S325-S326

2022

Volltextzugriff (PDF)

EP10.01-14 Efficacy and Safety of Nintedanib and Docetaxel in Patients with Lung Adenocarcinoma: A Multicenter Real-world Analysis

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S607

2023

Volltextzugriff (PDF)

1683P SARS-CoV-2 infection and lung cancer management in Europe

Annals of oncology, 2020-09, Vol.31, p.S996-S997

2020

Volltextzugriff (PDF)

1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression

Annals of oncology, 2021-09, Vol.32, p.S1166-S1166

2021

Volltextzugriff (PDF)

1323P Immunotherapy for PDL1-high (TPS≥50%) metastatic NSCLC: Results in real-world oncology practice

Annals of oncology, 2021-09, Vol.32, p.S1015-S1015

2021

Volltextzugriff (PDF)

P2.05-18 Tissue Sampling and Prognostic Biomarkers Analysis of Peripheral Lung Tumors Using R-EBUS. Single Centre Retrospective Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S754-S754

2019

Volltextzugriff (PDF)

R2216 One-year surveillance study in patients with pulmonary infections caused by anaerobic bacteria

International journal of antimicrobial agents, 2007, Vol.29, p.S642-S642

2007

Volltextzugriff (PDF)

P3.01-08 Gender Differences in Lung Cancer Survival

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S870-S870

2018

Volltextzugriff (PDF)

Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924

European journal of cancer (1990), 2020-10, Vol.138, p.S5-S5

2020

Volltextzugriff (PDF)

P1.09-10 Molecular Immunocytochemistry in Various NSCLC Samples Prepared as Non-Cell Block Cytology

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S499-S499

2019

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(84)
Croatian
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Microbiological criteria in non-tuberculous mycobacteria pulmonary disease: a tool for diagnosis and epidemiology

Geographical distribution and clinical relevance of non-tuberculous mycobacteria in Croatia

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

Coaching to develop teacher professional noticing: planning with students and mathematics in mind

Reconceptualizing risk: toward a theory of small risks in informal family play settings

Persistent endothelial dysfunction turns the frequent exacerbator COPD from respiratory disorder into a progressive pulmonary and systemic vascular disease

SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS

Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature

1394P Real-world experience in treatment of patients with non-small cell lung cancer with BRAF and cMET Exon 14 skipping mutations

107P IMPACT OF PREINTERVENTIONAL PLASMA FIBRINOGEN AS A PROGNOSTIC MARKER IN MALIGNANT PLEURAL MESOTHELIOMA

EP07.01-012 Ipilimumab and Nivolumab in Pretreated Patients with Malignant Pleural Mesothelioma

EP11.01-03 Neutrophil to Lymphocite Ratio in Patients Treated with Immunotherapy after Progression on Chemotherapy

P2.04-01 Lung Cancer Patient Experience Survey from Twelfth Central and Eastern Europe Countries

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

EP07.02-001 Evaluation of FGF18 as a Contributing Factor in Malignant Pleural Mesothelioma Growth and Its Role as a Potential Biomarker

EP10.01-14 Efficacy and Safety of Nintedanib and Docetaxel in Patients with Lung Adenocarcinoma: A Multicenter Real-world Analysis

1683P SARS-CoV-2 infection and lung cancer management in Europe

1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression

1323P Immunotherapy for PDL1-high (TPS≥50%) metastatic NSCLC: Results in real-world oncology practice

P2.05-18 Tissue Sampling and Prognostic Biomarkers Analysis of Peripheral Lung Tumors Using R-EBUS. Single Centre Retrospective Study

R2216 One-year surveillance study in patients with pulmonary infections caused by anaerobic bacteria

P3.01-08 Gender Differences in Lung Cancer Survival

Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924

P1.09-10 Molecular Immunocytochemistry in Various NSCLC Samples Prepared as Non-Cell Block Cytology

Suchergebnisse filtern